Ludwig Maximilian University of Munich (LMU)

15 PhD Positions in chromatin heterogeneity, single-cell technology and infection biology available within the Innovative Training Network (ITN) Cell2Cell

Cell2Cell ITN

Munich, Bavaria, Germany; Rehovot, Israel; Basel, Basel-Stadt, Switzerland; Stockholm, Sweden; Oxford, South East England, United Kingdom; Lisbon, Portugal; Paris, France; Nijmegen, Netherlands; Istanbul, Turkey; Budapest, Hungary

15 positions are available for a 3-year PhD program at institutions across Europe. The positions are funded by the new Marie Sklodowska-Curie Innovative Training Network (ITN) Cell2Cell


Deadline: February 15, 2020

Cell2Cell is an international network of leading academic institutions and industry groups, which provides multidisciplinary and intersectoral training for 15 early stage researchers (ESRs) in the fields of pathogen biology, chromatin biology, bioinformatics and single-cell methods. Cell2Cell investigates how cell-to-cell heterogeneity in chromatin enables pathogens to overcome challenges critical to establish persistent infections. To address this question, the research program aims to link changes in chromatin structures and genome organization to the adaptation of pathogens to their host environment. A strong focus is placed on the development of novel single-cell technologies to better study cell-to-cell heterogeneity.

General information:

  • You will be employed by the host organization for the duration of the PhD.
  • You will receive a competitive salary and travel allowance.
  • You will benefit from a comprehensive research program in the areas of infection biology, yeast chromatin biology, single-cell biology and bioinformatics
  • You will be part of an international network and participate in joint activities within the program (retreats, training workshops, summer school & conference).
  • You will participate in international visits to other organizations within the Cell2Cell network.

Eligibility criteria:

  1. Applicants can be of any nationality.
  2. Applicants must fulfill the mobility rule, i.e. have resided or carried out their main activity (work, studies, etc.) in the country of the host organization for no more than 12 months in the 3 years immediately before the recruitment date.
  3. Applicants must fulfill the Early Stage Researchers (ESRs) rule, i.e. be within their first four years (full-time equivalent research experience) of their research careers at the date of recruitment by the host organization and have not been awarded a doctoral degree.

General requirements:

  1. Entry level: Applicants should hold a Master’s degree (MSc) in biology, biochemistry, bioinformatics, biophysics, biotechnology, medicine or in a related discipline (candidates only holding a 4-years bachelor’s degree with honors can be considered under special circumstances).
  2. Language skills: A high proficiency in spoken and written English is required.
  3. Application process: After registration to the Cell2Cell online application: https://www.portal.graduatecenter.uni-muenchen.de/ocgc/cell2cell, enter the required information including motivation (outlining why and which projects you like to join) and upload the following documents: a short CV, copies of relevant transcripts and Master’s and Bachelor’s degree certificates.

For more information please visit the webpage www.cell2cell.eu. Deadline for submitting your online application is February 15, 2020.  

 

Recruiting academic institutions and industry groups:

Cellsorter (Budapest, HU), Epigenetiks (Istanbul, TR), Helmholtz Zentrum Munich (DE), Institut Curie (Paris, FR), Instituto de Medicina Molecular (Lisbon, PT), Karolinska Institutet (Stockholm, SW); Ludwig-Maximilians-University Munich (DE), Swiss Tropical and Public Health Institute (Basel, CH), University of Oxford (UK), Weizmann Institute of Science (Rehovot, IL),

H2020-MSCA-ITN-2019 project (grant no 860675)

Please apply via recruiter’s website.

Favorite